Pneumocystis carinii major surface glycoprotein induces interleukin‐8 and monocyte chemoattractant protein‐1 release from a human alveolar epithelial cell line

The major surface glycoprotein (MSG) is an abundant, immunogenic glycoprotein located on the surface of Pneumocystis carinii. Little is known about the proinflammatory effects of MSG.

[1]  J. Lundgren,et al.  The Pneumocystis carinii major surface glycoprotein (MSG): its potential involvement in the pathophysiology of pneumocystosis. , 1998, FEMS immunology and medical microbiology.

[2]  Sheldon,et al.  Pneumocystis carinii induces interleukin 6 production by an alveolar epithelial cell line , 1998, European journal of clinical investigation.

[3]  P. Barnes,et al.  Chemokine Production by a Human Alveolar Epithelial Cell Line in Response to Mycobacterium tuberculosis , 1998, Infection and Immunity.

[4]  J. Treml,et al.  Pneumocystis carinii glycoprotein A inhibits surfactant phospholipid secretion by rat alveolar type II cells. , 1998, The Journal of infectious diseases.

[5]  A. Limper,et al.  Pneumocystis carinii induces ICAM-1 expression in lung epithelial cells through a TNF-alpha-mediated mechanism. , 1997, The American journal of physiology.

[6]  J. Shelhamer,et al.  The major surface glycoprotein of Pneumocystis carinii induces release and gene expression of interleukin-8 and tumor necrosis factor alpha in monocytes , 1997, Infection and immunity.

[7]  J. Lundgren,et al.  Alveolar damage in AIDS-related Pneumocystis carinii pneumonia. , 1997, Chest.

[8]  C. Hack,et al.  Role of cytokines in sepsis. , 1997, Advances in immunology.

[9]  J. Treml,et al.  Pneumocystis carinii Glycoprotein A Stimulates Interleukin‐8 Production and Inflammatory Cell Activation in Alveolar Macrophages and Cultured Monocytes , 1996, Journal of Eukaryotic Microbiology.

[10]  A. Prince,et al.  Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. , 1995, The Journal of clinical investigation.

[11]  J. Shelhamer,et al.  Interleukin-8 and eicosanoid production in the lung during moderate to severe Pneumocystis carinii pneumonia in AIDS: a role of interleukin-8 in the pathogenesis of P. carinii pneumonia. , 1995, Respiratory medicine.

[12]  S. Morton,et al.  Reconsidering the use of adjunctive corticosteroids in Pneumocystis pneumonia? , 1995, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.

[13]  J. Lundgren,et al.  Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. , 1995, American journal of respiratory and critical care medicine.

[14]  D. Taub,et al.  Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. , 1995, The Journal of clinical investigation.

[15]  M. Kagnoff,et al.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. , 1995, The Journal of clinical investigation.

[16]  P. Walzer,et al.  Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii , 1993, Infection and immunity.

[17]  E. Eden,et al.  Effect of Corticosteroids on IL1β and TNFα Release by Alveolar Macrophages From Patients With AIDS and Pneumocystis carinii Pneumonia , 1993 .

[18]  J. Lundgren,et al.  Amount of Pneumocystis carinii and degree of acute lung inflammation in HIV-associated P carinii pneumonia. , 1993, Chest.

[19]  J. Standing,et al.  Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. , 1993, Journal of immunology.

[20]  E. Eden,et al.  Correlation of bronchoalveolar lavage findings to severity of Pneumocystis carinii pneumonia in AIDS. Evidence for the development of high-permeability pulmonary edema. , 1992, Chest.

[21]  A. Limper,et al.  Modulation of Pneumocystis carinii adherence to cultured lung cells by a mannose-dependent mechanism. , 1991, The Journal of laboratory and clinical medicine.

[22]  D. Williams,et al.  Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor , 1991, Nature.

[23]  J. Kovacs,et al.  Purification and characterization of a major human Pneumocystis carinii surface antigen. , 1991, The Journal of clinical investigation.

[24]  T. Standiford,et al.  Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. , 1991, Experimental lung research.

[25]  F. Ognibene,et al.  Atypical Pathologic Manifestations of Pneumocystis carinii Pneumonia in the Acquired Immune Deficiency Syndrome: Review of 123 Lung Biopsies from 76 Patients with Emphasis on Cysts, Vascular Invasion, Vasculitis, and Granulomas , 1990, The American journal of surgical pathology.

[26]  W. Martin,et al.  Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. , 1990, The Journal of clinical investigation.

[27]  A. Limper,et al.  Pneumocystis carinii: inhibition of lung cell growth mediated by parasite attachment. , 1990, The Journal of clinical investigation.

[28]  T. F. Smith,et al.  Pneumocystis carinii Pneumonia: Differences in Lung Parasite Number and Inflammation in Patients with and without AIDS , 1989 .

[29]  D. Stover,et al.  Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. , 1989, The American review of respiratory disease.

[30]  K. Matsushima,et al.  Brief Definitive Report Purification and Characterization of a Novel Monocyte Chemotactic and Activating Factor Produced by a Human Myelomonocytic Cell Line , 2022 .

[31]  W. El-Sadr,et al.  Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia. , 1988, Chest.

[32]  A. Fishman,et al.  Alveolar response to experimental Pneumocystis carinii pneumonia in the rat. , 1980, The American journal of pathology.